Atopic Dermatitis Clinical Trial in Moraga CA

Moderate to Severe Atopic Dermatitis Clinical Trial

Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.

Study Overview

  • Ages: 18 to 65 are eligible
    Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
  • Study Duration: 9 clinic visits over 6 months
  • Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis

Atopic Dermatitis Clinical Trial in Loma Mar CA

Moderate to Severe Atopic Dermatitis Clinical Trial

Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.

Study Overview

  • Ages: 18 to 65 are eligible
    Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
  • Study Duration: 9 clinic visits over 6 months
  • Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis

Atopic Dermatitis Clinical Trial in Half Moon Bay CA

Moderate to Severe Atopic Dermatitis Clinical Trial

Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.

Study Overview

  • Ages: 18 to 65 are eligible
    Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
  • Study Duration: 9 clinic visits over 6 months
  • Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis

Atopic Dermatitis Clinical Trial in San Gregorio CA

Moderate to Severe Atopic Dermatitis Clinical Trial

Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.

Study Overview

  • Ages: 18 to 65 are eligible
    Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
  • Study Duration: 9 clinic visits over 6 months
  • Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis

Atopic Dermatitis Clinical Trial in Diablo CA

Moderate to Severe Atopic Dermatitis Clinical Trial

Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.

Study Overview

  • Ages: 18 to 65 are eligible
    Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
  • Study Duration: 9 clinic visits over 6 months
  • Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis

Atopic Dermatitis Clinical Trial in San Francisco CA

Moderate to Severe Atopic Dermatitis Clinical Trial

Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.

Study Overview

  • Ages: 18 to 65 are eligible
    Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
  • Study Duration: 9 clinic visits over 6 months
  • Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis

Atopic Dermatitis Clinical Trial in Burlingame CA

Moderate to Severe Atopic Dermatitis Clinical Trial

Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.

Study Overview

  • Ages: 18 to 65 are eligible
    Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
  • Study Duration: 9 clinic visits over 6 months
  • Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis

Atopic Dermatitis Clinical Trial in Danville CA

Moderate to Severe Atopic Dermatitis Clinical Trial

Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.

Study Overview

  • Ages: 18 to 65 are eligible
    Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
  • Study Duration: 9 clinic visits over 6 months
  • Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis

Atopic Dermatitis Clinical Trial in Alameda CA

Moderate to Severe Atopic Dermatitis Clinical Trial

Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.

Study Overview

  • Ages: 18 to 65 are eligible
    Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
  • Study Duration: 9 clinic visits over 6 months
  • Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis

Atopic Dermatitis Clinical Trial in La Honda CA

Moderate to Severe Atopic Dermatitis Clinical Trial

Center for Dermatology Clinical Research is conducting a new clinical study evaluating potential options for moderate to severe atopic dermatitis patients.

Study Overview

  • Ages: 18 to 65 are eligible
    Compensation: Compensation for your time and travel is available and study-related medication/lab tests provided at no cost
  • Study Duration: 9 clinic visits over 6 months
  • Study Purpose: This study is evaluating the safety and efficacy of an investigational subcutaneous injection treatment for atopic dermatitis